The circulating levels showed a decreasing trend in 12 patients (85.7%), while only 2 patients (14.3%) showed increased plasma concentrations ( Fig. 2 ). 3.5.
← all excerpts
Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody.
1
—
—